GlaxoSmithKline (GSK) Reports Q3 EPS of30.5c; Revs Ease

October 23, 2013 7:15 AM

GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of $0.31, versus ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found